Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
Recent Share tips:
- Buy ITV (ITV) by Shore Capital
- Buy BP (BP.) by DZ Bank
- Sell Anglo American (AAL) by DZ Bank
- Sector Perform Paragon Banking Group (PAG) by RBC Capital
- Buy Just Eat Takeaway.Com N.V. (CDI) (JET) by Goldman Sachs
- Neutral Meggitt (MGGT) by Exane
- Buy BP (BP.) by UBS
- Sell Fresnillo (FRES) by UBS
- Neutral Meggitt (MGGT) by UBS
- Neutral Ascential (ASCL) by Citi
- Buy Direct Line Insurance Group (DLG) by Citi
- Buy BAE Systems (BA.) by Jonathan Smith in The Motley Fool
- Outperform Taylor Wimpey (TW.) by Credit Suisse
- Avoid Supply@Me Capital (SYME) by Tom Winnifrith in ShareProphets
- Buy Morgan Sindall Group (MGNS) by Alan Oscroft in The Motley Fool
- Watch Rolls-Royce Holdings (RR.) by Manika Premsingh in The Motley Fool
- Buy BAE Systems (BA.) by Royston Wild in The Motley Fool
- Buy Rightmove (RMV) by Harshil Patel in The Motley Fool
- Buy Diageo (DGE) by Harshil Patel in The Motley Fool
- Buy Aviva (AV.) by Jonathan Smith in The Motley Fool
Vectura Group (VEC)
Health Care Sector
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Vectura Group Overview
Vectura develops inhaled therapies principally for the treatment of respiratory diseases. Inhaled formulation development is increasingly complex with a wide variety of small molecules and biologics, increasing use of combination products and the need for targeted lung delivery or deep lung deposition for systemic delivery. We offer formulation services for DPI, pMDI and nebuliser development, including small molecules and biologics, complex combinations and generic products.Latest Vectura Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Peel Hunt | – | 2021-07-09 10:25:00 09/07/2021 | – |
| – | Shore Capital | – | 2021-05-26 18:00:00 26/05/2021 | – |
| – | Panmure Gordon | – | 2021-05-26 14:25:00 26/05/2021 | – |
| – | Peel Hunt | – | 2021-05-26 11:10:00 26/05/2021 | – |
| – | JP Morgan | – | 2021-03-19 07:30:00 19/03/2021 | – |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Vectura Group Overview
Vectura develops inhaled therapies principally for the treatment of respiratory diseases. Inhaled formulation development is increasingly complex with a wide variety of small molecules and biologics, increasing use of combination products and the need for targeted lung delivery or deep lung deposition for systemic delivery. We offer formulation services for DPI, pMDI and nebuliser development, including small molecules and biologics, complex combinations and generic products.Latest Vectura Group Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Peel Hunt | – | 2021-07-09 10:25:00 09/07/2021 | – |
| – | Shore Capital | – | 2021-05-26 18:00:00 26/05/2021 | – |
| – | Panmure Gordon | – | 2021-05-26 14:25:00 26/05/2021 | – |
| – | Peel Hunt | – | 2021-05-26 11:10:00 26/05/2021 | – |
| – | JP Morgan | – | 2021-03-19 07:30:00 19/03/2021 | – |